Bioavailability of Dabigatran Etexilate with Pantoprazole and Food

Phase 1, randomised, open-label trial of dabigatran in thromboembolism (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area under the plasma concentration-time curve of BIBR 953 ZW from 0 extrapolated to infinity at 72 hours, Area under the plasma concentration-time curve of BIBR 953 ZW from 0 to the last quantifiable data point at 72 hours and 2 more. Started Mar 2002; status: completed.